These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 4632131

  • 1. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 2. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E, Rózewska M.
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C, Andreis G.
    G Ital Chemioter; 1966 Jul; 13(1):109-27. PubMed ID: 4967318
    [No Abstract] [Full Text] [Related]

  • 5. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M, Czajka-Kropaczek L, Ciechanowska A.
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract] [Full Text] [Related]

  • 6. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 7. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U, Briccarello L, Vercellino E.
    G Ital Mal Torace; 1968 Mar; 22(4):195-201. PubMed ID: 5743001
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic efficacy of the principal antitubercular drugs: an evaluation by antibiogram].
    Cremonte LG, Mantellini E.
    Minerva Med; 1989 Feb; 80(2):153-6. PubMed ID: 2494591
    [Abstract] [Full Text] [Related]

  • 9. [Monotherapy with ethambutol in chronic drug-resistant tuberculosis].
    Duchi G, Mostardini G, Palatresi R.
    Atti Accad Fisiocrit Siena Med Fis; 1967 Feb; 16(1):41-58. PubMed ID: 5621900
    [No Abstract] [Full Text] [Related]

  • 10. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A, Ciobanu V, Cojocaru G, Borşaru I, Ciobanu D, Spirescu G, Roşianu D, Pescariu M.
    Ftiziologia; 1971 Feb; 20(6):623-8. PubMed ID: 5162289
    [No Abstract] [Full Text] [Related]

  • 11. [Late results of treatment of chronic pulmonary tuberculosis with ethambutol and capreomycin].
    Polaczek E, Lachowicz E, Araszkiewicz W, Kozakow H, Kazimierczak A, Pszonicka A, Potworowska M, Janowiec M, Styszewska H, Klimkiewicz H, Grabowska R.
    Gruzlica; 1973 Jul; 41(7):789-93. PubMed ID: 4125930
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1968 Jul; 65():195-206. PubMed ID: 4978461
    [No Abstract] [Full Text] [Related]

  • 13. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P.
    Arch Monaldi; 1972 Jul; 27(4):403-17. PubMed ID: 4217597
    [No Abstract] [Full Text] [Related]

  • 14. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z.
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract] [Full Text] [Related]

  • 15. Niacin-negative Mycobacterium tuberculosis.
    Tsukamura M.
    Am Rev Respir Dis; 1974 Jul; 110(1):101-3. PubMed ID: 4209362
    [No Abstract] [Full Text] [Related]

  • 16. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974 Jul; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 17. [Ethambutol in phthisiological experimentation and practice].
    Galassi A, Campanini A, Ciaccia A.
    G Ital Chemioter; 1966 Jul; 13(1):90-108. PubMed ID: 4967907
    [No Abstract] [Full Text] [Related]

  • 18. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S.
    Rev Clin Esp; 1972 May 31; 125(4):353-6. PubMed ID: 5080180
    [No Abstract] [Full Text] [Related]

  • 19. Primary drug resistant tuberculosis in Puerto Rico.
    Zack MB, Figueroa-Lebrón RE.
    Bol Asoc Med P R; 1974 Nov 31; 65(11):262-6. PubMed ID: 4217187
    [No Abstract] [Full Text] [Related]

  • 20. [Experience with long-term application of ethambutol in ambulatory and hospitalized patients with chronic destructive tuberculosis of the lungs].
    Rudoi NM, Eisaev BA.
    Probl Tuberk; 1973 Nov 31; 51(1):42-6. PubMed ID: 4199376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.